Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 313842, 16 pages
http://dx.doi.org/10.1155/2015/313842
Review Article

Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators

1Laboratório de Imunologia Viral, IOC, FIOCRUZ, Avenida Brasil 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil
2Instituto de Bioquimica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, 21941-599 Rio de Janeiro, RJ, Brazil

Received 25 October 2014; Accepted 22 January 2015

Academic Editor: Trai-Ming Yeh

Copyright © 2015 Elzinandes Leal de Azeredo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Simmons, J. J. Farrar, N. van Vinh Chau, and B. Wills, “Current concepts: dengue,” The New England Journal of Medicine, vol. 366, no. 15, pp. 1423–1432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. J. Geiss, H. Stahla, A. M. Hannah, H. H. Gari, and S. M. Keenan, “Focus on flaviviruses: current and future drug targets,” Future Medicinal Chemistry, vol. 1, no. 2, pp. 327–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Green and A. Rothman, “Immunopathological mechanisms in dengue and dengue hemorrhagic fever,” Current Opinion in Infectious Diseases, vol. 19, no. 5, pp. 429–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-J. Chang, H.-W. Luh, S.-H. Wang, H.-J. Lin, S.-C. Lee, and S.-T. Hu, “The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein,” DNA and Cell Biology, vol. 20, no. 9, pp. 569–577, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “Structure of the dengue virus envelope protein after membrane fusion,” Nature, vol. 427, no. 6972, pp. 313–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. W. D. Crill and G.-J. J. Chang, “Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes,” Journal of Virology, vol. 78, no. 24, pp. 13975–13986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Weaver and N. Vasilakis, “Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease,” Infection, Genetics and Evolution, vol. 9, no. 4, pp. 523–540, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. M. Kassim, M. N. Izati, T. TgRogayah, Y. M. Apandi, and Z. Saat, “Use of dengue NS1 antigen for early diagnosis of dengue virus infection,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 42, no. 3, pp. 562–569, 2011. View at Google Scholar · View at Scopus
  9. M. da Rocha Queiroz Lima, R. M. R. Nogueira, H. G. Schatzmayr, A. M. B. de Filippis, D. Limonta, and F. B. dos Santos, “A new approach to dengue fatal cases diagnosis: NS1 antigen capture in tissues,” PLoS Neglected Tropical Diseases, vol. 5, no. 5, Article ID e1147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Somnuke, R. E. Hauhart, J. P. Atkinson, M. S. Diamond, and P. Avirutnan, “N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement,” Virology, vol. 413, no. 2, pp. 253–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. H. Libraty, P. R. Young, D. Pickering et al., “High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever,” The Journal of Infectious Diseases, vol. 186, no. 8, pp. 1165–1168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Munoz-Jordan, G. G. Sanchez-Burgos, M. Laurent-Rolle, and A. Garcia-Sastre, “Inhibition of interferon signaling by dengue virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 24, pp. 14333–14338, 2003. View at Google Scholar
  13. M. Jones, A. Davidson, L. Hibbert et al., “Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression,” Journal of Virology, vol. 79, no. 9, pp. 5414–5420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Erbel, N. Schiering, A. D'Arcy et al., “Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus,” Nature Structural and Molecular Biology, vol. 13, no. 4, pp. 372–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Leung, K. Schroder, H. White et al., “Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors,” Journal of Biological Chemistry, vol. 276, no. 49, pp. 45762–45771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Li, S. Clum, S. You, K. E. Ebner, and R. Padmanabhan, “The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids,” Journal of Virology, vol. 73, no. 4, pp. 3108–3116, 1999. View at Google Scholar · View at Scopus
  17. M.-P. Egloff, D. Benarroch, B. Selisko, J.-L. Romette, and B. Canard, “An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization,” The EMBO Journal, vol. 21, no. 11, pp. 2757–2768, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mazzon, M. Jones, A. Davidson, B. Chain, and M. Jacobs, “Dengue virus ns5 inhibits interferon-a signaling by blocking signal transducer and activator of transcription 2 phosphorylation,” Journal of Infectious Diseases, vol. 200, no. 8, pp. 1261–1270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Guzman, S. B. Halstead, H. Artsob et al., “Dengue: a continuing global threat,” Nature Reviews Microbiology, vol. 8, no. 12, supplement, pp. S7–S16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. WHO, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2009, http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
  21. F. A. Bozza, O. G. Cruz, S. M. O. Zagne et al., “Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity,” BMC Infectious Diseases, vol. 8, article 86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Harris, E. Videa, L. Pérez et al., “Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua,” The American Journal of Tropical Medicine and Hygiene, vol. 63, no. 1-2, pp. 5–11, 2000. View at Google Scholar · View at Scopus
  23. A. Balmaseda, S. N. Hammond, M. A. Pérez et al., “Short report: Assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 6, pp. 1059–1062, 2005. View at Google Scholar · View at Scopus
  24. WHO, Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 1997, http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/.
  25. J. Barniol, R. Gaczkowski, E. V. Barbato et al., “Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries,” BMC Infectious Diseases, vol. 11, article 106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Srikiatkhachorn and S. Green, “Markers of dengue disease severity,” Current Topics in Microbiology and Immunology, vol. 338, pp. 67–82, 2010. View at Google Scholar
  27. S. B. Halstead, “Pathogenisis of dengue: challenges to molecular biology,” Science, vol. 239, no. 4839, pp. 476–481, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. R. G. Webster, “Disquisitions of original antigenic sin. I. Evidence in man,” The Journal of Experimental Medicine, vol. 124, no. 3, pp. 331–345, 1966. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., “Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,” Nature Medicine, vol. 9, no. 7, pp. 921–927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Weiskopf and A. Sette, “T-cell immunity to infection with dengue virus in humans,” Frontiers in Immunology, vol. 5, article 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Jayashree, G. C. Manasa, P. Pallavi, and G. V. Manjunath, “Evaluation of platelets as predictive parameters in dengue fever,” Indian Journal of Hematology and Blood Transfusion, vol. 27, no. 3, pp. 127–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Mitrakul, “Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 18, no. 3, pp. 407–412, 1987. View at Google Scholar · View at Scopus
  33. T. Srichaikul and S. Nimmannitya, “Haematology in dengue and dengue haemorrhagic fever,” Bailliere's Best Practice and Research in Clinical Haematology, vol. 13, no. 2, pp. 261–276, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. F. R. F. G. Azin, R. P. Gonçalves, M. H. D. S. Pitombeira, D. M. Lima, and I. C. Branco, “Dengue: profile of hematological and biochemical dynamics,” Revista Brasileira de Hematologia e Hemoterapia, vol. 34, no. 1, pp. 36–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. G. N. Malavige, P. K. Ranatunga, V. G. N. S. Velathanthiri et al., “Patterns of disease in Sri Lankan dengue patients,” Archives of Disease in Childhood, vol. 91, no. 5, pp. 396–400, 2006. View at Google Scholar · View at Scopus
  36. L. C. S. Lum, A. Y. T. Goh, P. W. K. Chan, A.-L. M. El-Amin, and K. L. Sai, “Risk factors for hemorrhage in severe dengue infections,” The Journal of Pediatrics, vol. 140, no. 5, pp. 629–631, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Chaudhary, D. Khetan, S. Sinha et al., “Transfusion support to Dengue patients in a hospital based blood transfusion service in north India,” Transfusion and Apheresis Science, vol. 35, no. 3, pp. 239–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. R. N. Makroo, V. Raina, P. Kumar, and R. K. Kanth, “Role of platelet transfusion in the management of dengue patients in a tertiary care hospital,” Asian Journal of Transfusion Science, vol. 1, no. 1, pp. 4–7, 2007. View at Publisher · View at Google Scholar
  39. L. C. S. Lum, M. E.-A. Abdel-Latif, A. Y. T. Goh, P. W. K. Chan, and S. K. Lam, “Preventive transfusion in dengue shock syndrome—is it necessary?” Journal of Pediatrics, vol. 143, no. 5, pp. 682–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. I. H. Khan, E. Anwar, A. Agha et al., “Factors predicting severe dengue in patients with dengue fever,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 5, no. 1, Article ID e2013014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Kaur and G. Kaur, “Transfusion support in patients with dengue fever,” International Journal of Applied & Basic Medical Research, vol. 4, supplement 1, pp. S8–S12, 2014. View at Publisher · View at Google Scholar
  42. B. Murgue, O. Cassar, M. Guigon, and E. Chungue, “Dengue virus inhibits human hematopoietic progenitor growth in vitro,” Journal of Infectious Diseases, vol. 175, no. 6, pp. 1497–1501, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Basu, P. Jain, S. V. Gangodkar, S. Shetty, and K. Ghosh, “Dengue 2 virus inhibits in vitro megakaryocytic colony formation and induces apoptosis in thrombopoietin-inducible megakaryocytic differentiation from cord blood CD34+ cells,” FEMS Immunology & Medical Microbiology, vol. 53, no. 1, pp. 46–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Nakao, C.-J. Lai, and N. S. Young, “Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines,” Blood, vol. 74, no. 4, pp. 1235–1240, 1989. View at Google Scholar · View at Scopus
  45. R. Edelman, S. Nimmannitya, R. W. Colman, R. C. Talamo, and F. H. Top Jr., “Evaluation of the plasma kinin system in dengue hemorrhagic fever,” The Journal of Laboratory and Clinical Medicine, vol. 86, no. 3, pp. 410–421, 1975. View at Google Scholar · View at Scopus
  46. E. D. Hottz, M. F. Oliveira, P. C. G. Nunes et al., “Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases,” Journal of Thrombosis and Haemostasis, vol. 11, no. 5, pp. 951–962, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-F. Lin, S.-W. Wan, H.-J. Cheng, H.-Y. Lei, and Y.-S. Lin, “Autoimmune pathogenesis in dengue virus infection,” Viral Immunology, vol. 19, no. 2, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Funahara, Sumarmo, and R. Wirawan, “Features of DIC in dengue hemorrhagic fever,” Bibliotheca Haematologica, vol. 49, pp. 201–211, 1983. View at Google Scholar · View at Scopus
  49. B. S. Coller and S. J. Shattil, “The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend,” Blood, vol. 112, no. 8, pp. 3011–3025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. J. E. Freedman, “Molecular regulation of platelet-dependent thrombosis,” Circulation, vol. 112, no. 17, pp. 2725–2734, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. B. A. Bouchard and P. B. Tracy, “Platelets, leukocytes, and coagulation,” Current Opinion in Hematology, vol. 8, no. 5, pp. 263–269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. M. Ruggeri and G. L. Mendolicchio, “Adhesion mechanisms in platelet function,” Circulation Research, vol. 100, no. 12, pp. 1673–1685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Furie and B. C. Furie, “Mechanisms of thrombus formation,” The New England Journal of Medicine, vol. 359, no. 9, pp. 938–949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Rivera, M. L. Lozano, L. Navarro-Núñez, and V. Vicente, “Platelet receptors and signaling in the dynamics of thrombus formation,” Haematologica, vol. 94, no. 5, pp. 700–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Davì and C. Patrono, “Platelet activation and atherothrombosis,” The New England Journal of Medicine, vol. 357, no. 24, pp. 2482–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Gawaz, H. Langer, and A. E. May, “Platelets in inflammation and atherogenesis,” The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3378–3384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Nieswandt, D. Varga-Szabo, and M. Elvers, “Integrins in platelet activation,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 206–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Kaushansky, “Lineage-specific hematopoietic growth factors,” The New England Journal of Medicine, vol. 354, no. 19, pp. 2034–2045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. J. W. Semple, D. Provan, M. B. Garvey, and J. Freedman, “Recent progress in understanding the pathogenesis of immune thrombocytopenia,” Current Opinion in Hematology, vol. 17, no. 6, pp. 590–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. W. Semple, J. E. Italiano Jr., and J. Freedman, “Platelets and the immune continuum,” Nature Reviews Immunology, vol. 11, no. 4, pp. 264–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. P. A. Holme, F. Brosstad, and N. O. Solum, “Platelet-derived microvesicles and activated platelets express factor Xa activity,” Blood Coagulation & Fibrinolysis, vol. 6, no. 4, pp. 302–310, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Labiós, M. Martínez, F. Gabriel, V. Guiral, S. Ruiz-Aja, and J. Aznar, “Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS,” Thrombosis Research, vol. 117, no. 4, pp. 403–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. X. Anand, J. F. Viles-Gonzalez, J. J. Badimon, E. Cavusoglu, and J. D. Marmur, “Membrane-associated CD40L and sCD40L in atherothrombotic disease,” Thrombosis and Haemostasis, vol. 90, no. 3, pp. 377–384, 2003. View at Google Scholar · View at Scopus
  64. M. Hammwöhner, A. Ittenson, J. Dierkes et al., “Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation,” Experimental Biology and Medicine, vol. 232, no. 4, pp. 581–589, 2007. View at Google Scholar · View at Scopus
  65. J. E. Italiano Jr., J. L. Richardson, S. Patel-Hett et al., “Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released,” Blood, vol. 111, no. 3, pp. 1227–1233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. G. C. White II and R. Rompietti, “Platelet secretion: indiscriminately spewed forth or highly orchestrated?” Journal of Thrombosis and Haemostasis, vol. 5, no. 10, pp. 2006–2008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Sehgal and B. Storrie, “Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release,” Journal of Thrombosis and Haemostasis, vol. 5, no. 10, pp. 2009–2016, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Lindemann and M. Gawaz, “The active platelet: translation and protein synthesis in an anucleate cell,” Seminars in Thrombosis and Hemostasis, vol. 33, no. 2, pp. 144–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. P. N. Shashkin, G. T. Brown, A. Ghosh, G. K. Marathe, and T. M. McIntyre, “Lipopolysaccharide is a direct agonist for platelet RNA splicing,” The Journal of Immunology, vol. 181, no. 5, pp. 3495–3502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. A. N. Wicki, A. Walz, S. N. Gerber-Huber, R. H. Wenger, R. Vornhagen, and K. J. Clemetson, “Isolation and characterization of human blood platelet mRNA and construction of a cDNA library in lambda gt11. Confirmation of the platelet derivation by identification of GPIb coding mRNA and cloning of a GPIb coding cDNA insert,” Thrombosis and Haemostasis, vol. 61, no. 3, pp. 448–453, 1989. View at Google Scholar · View at Scopus
  71. M. M. Denis, N. D. Tolley, M. Bunting et al., “Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets,” Cell, vol. 122, no. 3, pp. 379–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. Coppinger, R. O'Connor, K. Wynne et al., “Moderation of the platelet releasate response by aspirin,” Blood, vol. 109, no. 11, pp. 4786–4792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. A. S. Weyrich, S. Lindeaaann, and G. A. Zimmerman, “The evolving role of platelets in inflammation,” Journal of Thrombosis and Haemostasis, vol. 1, no. 9, pp. 1897–1905, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. A. S. Weyrich and G. A. Zimmerman, “Platelets: signaling cells in the immune continuum,” Trends in Immunology, vol. 25, no. 9, pp. 489–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Trzeciak-Ryczek, B. Tokarz-Deptuła, and W. Deptuła, “Platelets—an important element of the immune system,” Polish Journal of Veterinary Sciences, vol. 16, no. 2, pp. 407–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. S. P. Watson, J. M. J. Herbert, and A. Y. Pollitt, “GPVI and CLEC-2 in hemostasis and vascular integrity,” Journal of Thrombosis and Haemostasis, vol. 8, no. 7, pp. 1456–1467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Kasirer-Friede, M. L. Kahn, and S. J. Shattil, “Platelet integrins and immunoreceptors,” Immunological Reviews, vol. 218, no. 1, pp. 247–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Boulaftali, P. R. Hess, T. M. Getz et al., “Platelet ITAM signaling is critical for vascular integrity in infammation,” The Journal of Clinical Investigation, vol. 123, no. 2, pp. 908–916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. R. S. Kasthuri, S. L. Glover, J. Boles, and N. MacKman, “Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays,” Seminars in Thrombosis and Hemostasis, vol. 36, no. 7, pp. 764–771, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. V. Daubie, R. Pochet, S. Houard, and P. Philippart, “Tissue factor: a mini-review,” Journal of Tissue Engineering and Regenerative Medicine, vol. 1, no. 3, pp. 161–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. A. P. Owens III and N. Mackman, “Tissue factor and thrombosis: the clot starts here,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 432–439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. P. M. Fernandez and F. R. Rickles, “Tissue factor and angiogenesis in cancer,” Current Opinion in Hematology, vol. 9, no. 5, pp. 401–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. E. M. Egorina, M. A. Sovershaev, G. Bjørkøy et al., “Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1493–1498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Osterud and E. Bjorklid, “Tissue factor in blood cells and endothelial cells,” Frontiers in Bioscience, vol. 4, no. 1, pp. 289–299, 2012. View at Google Scholar · View at Scopus
  85. M. L. López, N. Soriano-Sarabia, G. Bruges et al., “Expression pattern of protease activated receptors in lymphoid cells,” Cellular Immunology, vol. 288, no. 1-2, pp. 47–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. V. S. Ossovskaya and N. W. Bunnett, “Protease-activated receptors: contribution to physiology and disease,” Physiological Reviews, vol. 84, no. 2, pp. 579–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. E. Camerer, W. Huang, and S. R. Coughlin, “Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 10, pp. 5255–5260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. R. Ramachandran and M. D. Hollenberg, “Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more,” British Journal of Pharmacology, vol. 153, supplement 1, pp. S263–S282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. W. Ruf, “Protease-activated receptor signaling in the regulation of inflammation,” Critical Care Medicine, vol. 32, no. 5, supplement, pp. S287–S292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. J. P. Chen and T. M. Cosgriff, “Hemorrhagic fever virus-induced changes in hemostasis and vascular biology,” Blood Coagulation & Fibrinolysis, vol. 11, no. 5, pp. 461–483, 2000. View at Google Scholar
  91. M. Levi, T. van der Poll, and H. R. Büller, “Bidirectional relation between inflammation and coagulation,” Circulation, vol. 109, no. 22, pp. 2698–2704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. W. Ruf, “Emerging roles of tissue factor in viral hemorrhagic fever,” Trends in Immunology, vol. 25, no. 9, pp. 461–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. A. R. Rezaie, “Regulation of the protein C anticoagulant and antiinflammatory pathways,” Current Medicinal Chemistry, vol. 17, no. 19, pp. 2059–2069, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Petäjä, “Inflammation and coagulation. An overview,” Thrombosis Research, vol. 127, supplement 2, pp. S34–S37, 2011. View at Publisher · View at Google Scholar
  95. T. van der Poll, J. D. D. de Boer, and M. Levi, “The effect of inflammation on coagulation and vice versa,” Current Opinion in Infectious Diseases, vol. 24, no. 3, pp. 273–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Levi, “The coagulant response in sepsis and inflammation,” Hamostaseologie, vol. 30, no. 1, pp. 10–16, 2010. View at Google Scholar · View at Scopus
  97. M. Levi and T. van der Poll, “Inflammation and coagulation,” Critical Care Medicine, vol. 38, no. 2, supplement, pp. S26–S34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. S. T. Olson and I. Bjork, “Regulation of thrombin activity by antithrombin and heparin,” Seminars in Thrombosis and Hemostasis, vol. 20, no. 4, pp. 373–409, 1994. View at Publisher · View at Google Scholar · View at Scopus
  99. S. A. Maroney and A. E. Mast, “Tissue factor pathway inhibitor and bacterial infection,” Journal of Thrombosis and Haemostasis, vol. 9, no. 1, pp. 119–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. I. Andia and M. Abate, “Platelet-rich plasma: underlying biology and clinical correlates,” Regenerative Medicine, vol. 8, no. 5, pp. 645–658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. J. F. Danielli, “Capillary permeability and oedema in the perfused frog,” Journal of Physiology, vol. 98, no. 1, pp. 109–129, 1940. View at Publisher · View at Google Scholar
  102. A. T. Nurden, P. Nurden, M. Sanchez, I. Andia, and E. Anitua, “Platelets and wound healing,” Frontiers in Bioscience, vol. 13, no. 9, pp. 3532–3548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. I. Andia, M. Sanchez, and N. Maffulli, “Tendon healing and platelet-rich plasma therapies,” Expert Opinion on Biological Therapy, vol. 10, no. 10, pp. 1415–1426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. A. J. Hayes and J. R. Ralphs, “The response of foetal annulus fibrosus cells to growth factors: modulation of matrix synthesis by TGF-β1 and IGF-1,” Histochemistry and Cell Biology, vol. 136, no. 2, pp. 163–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. T. G. Diacovo, K. D. Puri, R. A. Warnock, T. A. Springer, and U. H. von Andrian, “Platelet-mediated lymphocyte delivery to high endothelial venules,” Science, vol. 273, no. 5272, pp. 252–255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  106. P. André, L. Nannizzi-Alaimo, S. K. Prasad, and D. R. Phillips, “Platelet-derived CD40L: the switch-hitting player of cardiovascular disease,” Circulation, vol. 106, no. 8, pp. 896–899, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. L. K. Kho, H. Wulur, and T. Himawan, “Blood and bone marrow changes in dengue haemorrhagic fever,” Paediatrica Indonesiana, vol. 12, no. 1, pp. 31–39, 1972. View at Google Scholar · View at Scopus
  108. T. Srichaikul, “Disseminated intravascular coagulation in dengue haemorrhagic fever,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 18, no. 3, pp. 303–311, 1987. View at Google Scholar · View at Scopus
  109. F. J. de Sauvage, P. E. Hass, S. D. Spencer et al., “Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand,” Nature, vol. 369, no. 6481, pp. 533–538, 1994. View at Publisher · View at Google Scholar · View at Scopus
  110. A. L. Gurney, K. Carver-Moore, F. J. de Sauvage, and M. W. Moore, “Thrombocytopenia in c-mpl-deficient mice,” Science, vol. 265, no. 5177, pp. 1445–1447, 1994. View at Publisher · View at Google Scholar · View at Scopus
  111. E. Putintseva, G. Vega, and L. Fernández, “Alterations in thrombopoiesis in patients with thrombocytopenia produced by dengue hemorrhagic fever,” Nouvelle Revue Française d'Hématologie, vol. 28, no. 5, pp. 269–273, 1986. View at Google Scholar · View at Scopus
  112. A. V. Matondang, D. Widodo, I. Zulkarnain et al., “The correlation between thrombopoietin and platelet count in adult dengue viral infection patients,” Acta medica Indonesiana, vol. 36, no. 2, pp. 62–69, 2004. View at Google Scholar · View at Scopus
  113. C. Krishnamurti, R. A. Peat, M. A. Cutting, and S. W. Rothwell, “Platelet adhesion to dengue-2 virus-infected endothelial cells,” The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 4, pp. 435–441, 2002. View at Google Scholar · View at Scopus
  114. T. Srichaikul, S. Nimmannitya, T. Sripaisarn, M. Kamolsilpa, and C. Pulgate, “Platelet function during the acute phase of dengue hemorrhagic fever,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 20, no. 1, pp. 19–25, 1989. View at Google Scholar · View at Scopus
  115. S. Honda, M. Saito, E. M. Dimaano et al., “Increased phagocytosis of platelets from patients with secondary dengue virus infection by human macrophages,” The American Journal of Tropical Medicine and Hygiene, vol. 80, no. 5, pp. 841–845, 2009. View at Google Scholar · View at Scopus
  116. C. F. Lin, H. Y. Lei, C. C. Liu et al., “Generation of IgM anti-platelet autoantibody in dengue patients,” Journal of Medical Virology, vol. 63, no. 2, pp. 143–149, 2001. View at Google Scholar
  117. H.-Y. Lei, T.-M. Yeh, H.-S. Liu, Y.-S. Lin, S.-H. Chen, and C.-C. Liu, “Immunopathogenesis of dengue virus infection,” Journal of Biomedical Science, vol. 8, no. 5, pp. 377–388, 2001. View at Publisher · View at Google Scholar · View at Scopus
  118. Y.-S. Lin, T.-M. Yeh, C.-F. Lin et al., “Molecular mimicry between virus and host and its implications for dengue disease pathogenesis,” Experimental Biology and Medicine, vol. 236, no. 5, pp. 515–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. M. T. G. Alonzo, T. L. V. Lacuesta, E. M. Dimaano et al., “Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections,” The Journal of Infectious Diseases, vol. 205, no. 8, pp. 1321–1329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Oishi, M. Saito, C. A. Mapua, and F. F. Natividad, “Dengue illness: clinical features and pathogenesis,” Journal of Infection and Chemotherapy, vol. 13, no. 3, pp. 125–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Saito, K. Oishi, S. Inoue et al., “Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections,” Clinical and Experimental Immunology, vol. 138, no. 2, pp. 299–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Boonpucknavig, O. Vuttiviroj, C. Bunnag, N. Bhamarapravati, and S. Nimmanitya, “Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 28, no. 5, pp. 881–884, 1979. View at Google Scholar · View at Scopus
  123. S. Noisakran, K. Chokephaibulkit, P. Songprakhon et al., “A re-evaluation of the mechanisms leading to dengue hemorrhagic fever,” Annals of the New York Academy of Sciences, vol. 1171, supplement 1, pp. E24–E35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. S. Noisakran, R. V. Gibbons, P. Songprakhon et al., “Detection of dengue virus in platelets isolated from dengue patients,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 40, no. 2, pp. 253–262, 2009. View at Google Scholar · View at Scopus
  125. S. Noisakran, N. Onlamoon, K. Pattanapanyasat et al., “Role of CD61+ cells in thrombocytopenia of dengue patients,” International Journal of Hematology, vol. 96, no. 5, pp. 600–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  126. A. L. Rothman and F. A. Ennis, “Immunopathogenesis of dengue hemorrhagic fever,” Virology, vol. 257, no. 1, pp. 1–6, 1999. View at Publisher · View at Google Scholar · View at Scopus
  127. B. A. Wills, E. E. Oragui, A. C. Stephens et al., “Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome,” Clinical Infectious Diseases, vol. 35, no. 3, pp. 277–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  128. B. Wills, T. V. Ngoc, N. T. H. Van et al., “Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding,” The American Journal of Tropical Medicine and Hygiene, vol. 81, no. 4, pp. 638–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. D. Sosothikul, P. Seksarn, S. Pongsewalak, U. Thisyakorn, and J. Lusher, “Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection,” Thrombosis and Haemostasis, vol. 97, no. 4, pp. 627–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. M. L. Avila-Aguero, C. R. Avila-Aguero, S. L. Um, A. Soriano-Fallas, A. Cañas-Coto, and S. B. Yan, “Systemic host inflammatory and coagulation response in the Dengue virus primo-infection,” Cytokine, vol. 27, no. 6, pp. 173–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. T.-S. Ho, S.-M. Wang, Y.-S. Lin, and C.-C. Liu, “Clinical and laboratory predictive markers for acute dengue infection,” Journal of Biomedical Science, vol. 20, no. 1, article 75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Funahara, K. Ogawa, N. Fujita, and Y. Okuno, “Three possible triggers to induce thrombocytopenia in dengue virus infection,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 18, no. 3, pp. 351–355, 1987. View at Google Scholar · View at Scopus
  133. E. F. Mammen, “Disseminated intravascular coagulation (DIC),” Clinical Laboratory Science, vol. 13, no. 4, pp. 239–245, 2000. View at Google Scholar · View at Scopus
  134. R. L. Bick, “Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: Guidelines for care,” Clinical and Applied Thrombosis/Hemostasis, vol. 8, no. 1, pp. 1–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  135. M. N. Chua, R. Molanida, M. de Guzman, and F. Laberiza, “Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 24, supplement 1, pp. 141–143, 1993. View at Google Scholar · View at Scopus
  136. J.-W. Liu, I.-K. Lee, L. Wang, R.-F. Chen, and K. D. Yang, “The usefulness of clinical-practice-based laboratory data in facilitating the diagnosis of dengue illness,” BioMed Research International, vol. 2013, Article ID 198797, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. H. Huang, C. C. Liu, S. T. Wang et al., “Activation of coagulation and fibrinolysis during dengue virus infection,” Journal of Medical Virology, vol. 63, no. 3, pp. 247–251, 2001. View at Google Scholar
  138. T. W. Geisbert, L. E. Hensley, T. Larsen et al., “Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection,” The American Journal of Pathology, vol. 163, no. 6, pp. 2347–2370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. T. W. Geisbert, L. E. Hensley, P. B. Jahrling et al., “Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys,” The Lancet, vol. 362, no. 9400, pp. 1953–1958, 2003. View at Publisher · View at Google Scholar · View at Scopus
  140. Z. Jiang, X. Tang, R. Xiao, L. Jiang, and X. Chen, “Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells,” The Journal of Infection, vol. 55, no. 2, pp. e23–e28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Huerta-Zepeda, C. Cabello-Gutiérrez, J. Cime-Castillo et al., “Crosstalk between coagulation and inflammation during Dengue virus infection,” Thrombosis and Haemostasis, vol. 99, no. 5, pp. 936–943, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. E. L. de Azeredo, C. F. Kubelka, L. M. Alburquerque et al., “Tissue factor expression on monocytes from patients with severe dengue fever,” Blood Cells, Molecules, and Diseases, vol. 45, no. 4, pp. 334–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. L. M. O. Pinto, S. A. Oliveira, E. L. A. Braga, R. M. R. Nogueira, and C. F. Kubelka, “Increased Pro-inflammatory Cytokines (TNF-α and IL-6) and Anti-inflammatory Compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever,” Memorias do Instituto Oswaldo Cruz, vol. 94, no. 3, pp. 387–394, 1999. View at Google Scholar · View at Scopus
  144. C. F. Kubelka, P. A. Borges, F. F. VonSydow, and E. Lampe, “Analysis of tumor necrosis factor-alpha serum level in Brazilian patients with Dengue-2,” Memórias do Instituto Oswaldo Cruz, vol. 90, no. 6, pp. 741–742, 1995. View at Publisher · View at Google Scholar · View at Scopus
  145. E. L. Azeredo, S. M. O. Zagne, M. A. Santiago et al., “Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever,” Immunobiology, vol. 204, no. 4, pp. 494–507, 2001. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Green, D. W. Vaughn, S. Kalayanarooj et al., “Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity,” The Journal of Infectious Diseases, vol. 179, no. 4, pp. 755–762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  147. D. Hober, A.-S. Delannoy, S. Benyoucef, D. de Groote, and P. Wattré, “High levels of sTNFR p75 and TNFα in dengue-infected patients,” Microbiology and Immunology, vol. 40, no. 8, pp. 569–573, 1996. View at Publisher · View at Google Scholar · View at Scopus
  148. F. A. Orsi, R. N. Angerami, B. M. Mazetto et al., “Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations,” BMC Infectious Diseases, vol. 13, no. 1, article 350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. S.-W. Lin, Y.-C. Chuang, Y.-S. Lin, H.-Y. Lei, H.-S. Liu, and T.-M. Yeh, “Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation,” Journal of Infection, vol. 64, no. 3, pp. 325–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. Y. C. Chuang, H. Y. Lei, Y. S. Lin, H. S. Liu, H. L. Wu, and T. M. Yeh, “Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation,” Journal of Immunology, vol. 187, no. 12, pp. 6483–6490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. K. D. Yang, C. S. Lee, and M. F. Shaio, “A higher production of platelet activating factor in ex vivo heterologously secondary dengue-2 virus infections,” Acta Microbiologica et Immunologica Hungarica, vol. 42, no. 4, pp. 403–407, 1995. View at Google Scholar · View at Scopus
  152. K. Ghosh, S. Gangodkar, P. Jain et al., “Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy,” Journal of Electron Microscopy (Tokyo), vol. 57, no. 3, pp. 113–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  153. S. Moncada and E. A. Higgs, “The discovery of nitric oxide and its role in vascular biology,” British Journal of Pharmacology, vol. 147, supplement 1, pp. S193–S201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. N. Valero, L. M. Espina, G. Añez, E. Torres, and J. A. Mosquera, “Short report: increased level of serum nitric oxide in patients with dengue,” The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 762–764, 2002. View at Google Scholar · View at Scopus
  155. L. R. Queen, B. Xu, K. Horinouchi, I. Fisher, and A. Ferro, “β2-Adrenoceptors activate nitric oxide synthase in human platelets,” Circulation Research, vol. 87, no. 1, pp. 39–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  156. J. R. Sheu, Y. C. Kan, W. C. Hung, C. H. Lin, and M. H. Yen, “The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase,” Life Sciences, vol. 67, no. 8, pp. 937–947, 2000. View at Publisher · View at Google Scholar · View at Scopus
  157. A. C. Mendes-Ribeiro, M. B. Moss, M. A. S. Siqueira et al., “Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human platelets,” Clinical and Experimental Pharmacology & Physiology, vol. 35, no. 10, pp. 1143–1146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  158. C. Matsuura, T. L. Moraes, J. B. Barbosa et al., “Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 106, no. 3, pp. 174–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Michels, B. Alisjahbana, P. G. de Groot et al., “Platelet function alterations in dengue are associated with plasma leakage,” Thrombosis and Haemostasis, vol. 112, no. 2, pp. 352–362, 2014. View at Publisher · View at Google Scholar
  160. S. Gudbrandsdottir, H. C. Hasselbalch, and C. H. Nielsen, “Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes,” The Journal of Immunology, vol. 191, no. 8, pp. 4059–4067, 2013. View at Publisher · View at Google Scholar · View at Scopus
  161. E. D. Hottz, I. M. Medeiros-de-Moraes, A. Vieira-de-Abreu et al., “Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue,” The Journal of Immunology, vol. 193, no. 4, pp. 1864–1872, 2014. View at Publisher · View at Google Scholar
  162. C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, pp. 197–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Andonegui, S. M. Kerfoot, K. McNagny, K. V. J. Ebbert, K. D. Patel, and P. Kubes, “Platelets express functional Toll-like receptor-4,” Blood, vol. 106, no. 7, pp. 2417–2423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. F. Cognasse, H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud, “Evidence of Toll-like receptor molecules on human platelets,” Immunology and Cell Biology, vol. 83, no. 2, pp. 196–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. R. Aslam, E. R. Speck, M. Kim et al., “Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo,” Blood, vol. 107, no. 2, pp. 637–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. P. Patrignani, C. di Febbo, S. Tacconelli et al., “Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo,” Blood, vol. 107, no. 9, pp. 3572–3574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. J. W. Semple, R. Aslam, M. Kim, E. R. Speck, and J. Freedman, “Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets,” Blood, vol. 109, no. 11, pp. 4803–4805, 2007. View at Google Scholar · View at Scopus
  168. G. Zhang, J. Han, E. J. Welch et al., “Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway,” Journal of Immunology, vol. 182, no. 12, pp. 7997–8004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. E. D. Hottz, J. F. Lopes, C. Freitas et al., “Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation,” Blood, vol. 122, no. 20, pp. 3405–3414, 2013. View at Publisher · View at Google Scholar
  170. K. Djamiatun, S. M. H. Faradz, T. E. Setiati, M. G. Netea, A. J. A. M. van der Ven, and W. M. V. Dolmans, “Increase of plasminogen activator inhibitor-1 and decrease of transforming growth factor-β1 in children with dengue haemorrhagic fever in Indonesia,” Journal of Tropical Pediatrics, vol. 57, no. 6, pp. 424–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. R. K. Assoian, A. Komoriya, C. A. Meyers, D. M. Miller, and M. B. Sporn, “Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization,” Journal of Biological Chemistry, vol. 258, no. 11, pp. 7155–7160, 1983. View at Google Scholar · View at Scopus
  172. P. O. Andersson, D. Stockelberg, S. Jacobsson, and H. Wadenvik, “A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura,” Annals of Hematology, vol. 79, no. 9, pp. 507–513, 2000. View at Publisher · View at Google Scholar · View at Scopus
  173. P.-O. Andersson, A. Olsson, and H. Wadenvik, “Reduced transforming growth factor-β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura,” British Journal of Haematology, vol. 116, no. 4, pp. 862–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  174. P. Butthep, A. Bunyaratvej, and N. Bhamarapravati, “Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 24, supplement 1, pp. 246–249, 1993. View at Google Scholar · View at Scopus
  175. K. Chen, T. C. Detwiler, and D. W. Essex, “Characterization of protein disulphide isomerase released from activated platelets,” British Journal of Haematology, vol. 90, no. 2, pp. 425–431, 1995. View at Publisher · View at Google Scholar · View at Scopus
  176. D. W. Essex and M. Li, “Protein disulphide isomerase mediates platelet aggregation and secretion,” British Journal of Haematology, vol. 104, no. 3, pp. 448–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  177. A. Rachman, A. R. Harahap, and R. M. Widhyasih, “The role of anti-dengue virus NS-1 and anti-protein disulfide isomerase antibodies on platelet aggregation in secondary dengue infection,” Acta medica Indonesiana, vol. 45, no. 1, pp. 44–48, 2013. View at Google Scholar · View at Scopus
  178. H.-J. Cheng, H.-Y. Lei, C.-F. Lin et al., “Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation,” Molecular Immunology, vol. 47, no. 2-3, pp. 398–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. R. C. S. Seet, A. W. L. Chow, A. M. L. Quek, Y.-H. Chan, and E. C. H. Lim, “Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study,” International Journal of Infectious Diseases, vol. 13, no. 5, pp. e248–e253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  180. P. Sathupan, A. Khongphattanayothin, J. Srisai, K. Srikaew, and Y. Poovorawan, “The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection,” Annals of Tropical Paediatrics, vol. 27, no. 3, pp. 179–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. A. Srikiatkhachorn, C. Ajariyakhajorn, T. P. Endy et al., “Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever,” Journal of Virology, vol. 81, no. 4, pp. 1592–1600, 2007. View at Publisher · View at Google Scholar · View at Scopus
  182. C.-S. Tseng, H.-W. Lo, H.-C. Teng, W.-C. Lo, and C.-G. Ker, “Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever,” FEMS Immunology and Medical Microbiology, vol. 43, no. 1, pp. 99–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. G. N. Malavige, L.-C. Huang, M. Salimi, L. Gomes, S. D. Jayaratne, and G. S. Ogg, “Cellular and cytokine correlates of severe dengue infection,” PLoS ONE, vol. 7, no. 11, Article ID e50387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. M. Michels, A. J. A. M. van der Ven, K. Djamiatun et al., “Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 5, pp. 943–946, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. E. D. Hottz, J. F. Lopes, C. Freitas et al., “Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation,” Blood, vol. 122, no. 20, pp. 3405–3414, 2013. View at Publisher · View at Google Scholar · View at Scopus